Crinetics Pharmaceuticals
Trade Crinetics Pharmaceuticals 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About CRNX
Crinetics Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its product candidate, CRN00808, is an oral nonpeptide somatostatin agonist for the treatment of acromegaly.
CRNX Key Statistics
Stock Snapshot
With a market cap of 5.57B, Crinetics Pharmaceuticals(CRNX) trades at $54.56. The stock has a price-to-earnings ratio of -11.98.
During the trading day, Crinetics Pharmaceuticals(CRNX) stock saw an opening price of $55.31, a peak of —, and a bottom of —.
Trading volume for Crinetics Pharmaceuticals(CRNX) stock has reached 0, versus its average volume of 2.19M.
Over the past 52 weeks, Crinetics Pharmaceuticals(CRNX) stock has traded between a high of $57.99 and a low of $24.10.
Over the past 52 weeks, Crinetics Pharmaceuticals(CRNX) stock has traded between a high of $57.99 and a low of $24.10.
CRNX News
Claim 70% Off TipRanks Premium Crinetics Pharmaceuticals ( (CRNX) ) just unveiled an update. On January 13, 2026, Crinetics Pharmaceuticals’ founder and CEO S...
Advertisement What Crinetics Pharmaceuticals Stock’s Recent Move Might Mean for Investors Crinetics Pharmaceuticals (CRNX) has drawn attention after recent sh...
